Exendin-4 Catalog No.:M9966-2 43)38-11-8-18(9-12-38)34-28(41)26-23(16-32-36-26)35-27(40)25-21(30)13-17(29)14-22(25)31/h3-7

43)38-11-8-18(9-12-38)34-28(41)26-23(16-32-36-26)35-27(40)25-21(30)13-17(29)14-22(25)31/h3-7

Barrientos JC

1007/s10495-015-1140-2

CAS Number: 405169-16-6

is a selective inhibitor of PDE5 (type 5 cGMP phosphodiesterase) which catalyzes the hydrolysis of 3'

Exendin-4 Catalog No.:M9966-2 43)38-11-8-18(9-12-38)34-28(41)26-23(16-32-36-26)35-27(40)25-21(30)13-17(29)14-22(25)31/h3-7Exenatide is a medication used to treat diabetes mellitus type 2. Exenatide binds to the intact human Glucagon like peptide 1 receptor (GLP 1R) in a similar way to the human peptide glucagon like peptide 1 (GLP 1); exenatide bears a 50% amino acid homology to GLP 1 and it has a longer half life in vivo. It is used together with diet, exercise, and potentially other antidiabetic medication. It is a less preferred treatment option after metformin and